Sterne Kessler’s Chandrika Vira spoke at the 17th Summit on Biosimilars & Innovator Biologics, hosted by ACI. Chandrika participated in the “In-House Roundtable Series,” an interactive forum designed to facilitate candid, high-value discussions among legal and industry leaders.

In a dynamic rotating roundtable format, Chandrika joined fellow in-house counsel, regulators, and trusted law firm partners to exchange practical insights, benchmark strategies, and address today’s most pressing challenges in the biosimilars and biologics landscape.

Attendees were encouraged to bring their toughest questions, key takeaways, and emerging perspectives as roundtable hosts rotated every 30 minutes to foster meaningful networking and collaborative discussion on the following topics:

  1. Skinny Labeling and Induced-Infringement Liability: Evolving Legal Standards and Implications for Launch Planning, Labeling, Marketing Strategies, and Litigation Risk with Skinny Label Carveouts
  2. Mastering the Changing BPCIA Landscape: Reviewing Litigation, Damages, Pricing and Settlement Negotiation Strategies
  3. Navigating the New PTAB: Investigating How the Clampdown of IPRs and PGRs Is Reshaping Patent Owner and Challenger Strategies

Sterne Kessler was also a conference sponsor.

Related Professionals

Related Industries